Showing results (331-340 of 411) with videos related to
Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP InhibitorsJonathan Chou, Troy M Robinson, Emily A Egusa, et al.Journal of the National Cancer Institute|April 5, 2012
CYP3A variation, premenopausal estrone levels, and breast cancer riskNichola Johnson, Kate Walker, Lorna J Gibson, et al.The Journal of Clinical Investigation|February 16, 2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockadeMehdi Touat, Tony Sourisseau, Nicolas Dorvault, et al.Nature|June 8, 2026
Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin ShreddingJingkun Zeng, Zhiyuan Cheng, Huadong Chen, et al.Cancer Research|August 30, 2014
Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signalingShan Gao, Ilirjana Bajrami, Clare Verrill, et al.Science Translational Medicine|September 3, 2011
Identification of a disease-defining gene fusion in epithelioid hemangioendotheliomaMunir R Tanas, Andrea Sboner, Andre M Oliveira, et al.Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.Biorxiv : the Preprint Server for Biology|June 6, 2025
Identification and Characterization of PLUTO-201, a Novel Long Non-Coding RNA Associated with Poor Outcomes in Prostate CancerHui Li, Noah S Younger, Bhavna Malik, et al.Biorxiv : the Preprint Server for Biology|July 28, 2023
NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapyAbrar Choudhury, Martha A Cady, Calixto-Hope G Lucas, et al.The Journal of Pathology|January 8, 2014
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breastRachael Natrajan, Paul M Wilkerson, Caterina Marchiò, et al.Pageof 42